Here’s the pitch you’ll see everywhere: a tidy number, usually “100 mcg,” delivered with the swagger of a nutrition label. Here’s the actual state of the evidence: one human study, a single dose, and a research design that never asked the questions you actually care about. I review things for a living, in the loose sense that I read the fine print so you don’t have to, and I have to tell you upfront that this product category gets an incomplete on its report card. Not a fail. An incomplete, because the test was never finished.
Let’s go through it properly.
The hype: “clinically dosed” protocols
Scroll any forum thread on CJC-1295 and you’ll find numbers presented like they came off a pharmacy insert. Twice weekly. Before bed. Always specific, always confident, never footnoted. It reads like settled science. It is not settled science, because there is no FDA-cleared label for this compound at all. Nothing is telling anyone how much to inject the way a bottle from a real pharmacy would, and no credential I could slap at the top of this page would change that. The proof, such as it is, lives in one paper. Let’s find out what that paper actually says, because it’s a lot thinner than the confidence around it.
Wait, which one are we even reviewing?
Before I grade anything, I need you to know there are two products wearing the same name, and mixing them up is the most common unforced error in this whole conversation.
CJC-1295 with DAC carries a chemical attachment (a drug affinity complex) that clings to albumin in your blood and refuses to let go. That grip stretches the half-life to several days, so one injection keeps a growth-hormone signal running for a good while. This is the version that got the actual human trial.
CJC-1295 without DAC, usually sold as mod-GRF 1-29, has no such handle. It’s in and out of your system in about thirty minutes, a short sharp pulse rather than a slow burn, which some people prefer because it mimics your body’s own natural GH bursts more closely.
Different shelf lives mean different dosing rhythms entirely, one taken rarely, one taken often and timed around things like sleep. So any dosing number you see with no mention of which version it’s describing is not a number worth reading. It’s a rumor wearing a lab coat.
The one study that exists, reviewed honestly
Here’s the entirety of the human data: a 2006 paper in the Journal of Clinical Endocrinology and Metabolism tested the DAC version as a single injection, at doses of 30 to 60 micrograms per kilogram of body weight [P1]. One shot raised growth hormone 2- to 10-fold for six days or more, lifted IGF-1 for nine to eleven days, and the half-life landed around 5.8 to 8.1 days. Tolerability over that short window was reported as relatively good [P1].
That’s a genuinely interesting result. It’s also the only result. Notice what it doesn’t cover. It’s weight-based dosing at research-trial scale, not the flat “100 mcg” figures traded online. It measured hormone levels in blood, full stop, nothing about muscle, fat, or any outcome a person is actually chasing. And it was a single dose with short follow-up, so it says nothing at all about what happens after weeks or months of repeated use, because nobody ran that study. If I’m grading the evidence on what it claims to know about single-dose hormone response, I’d call it solid, a B+. If I’m grading it on what people actually use it to justify, ongoing self-dosing for physique or longevity goals, that grade collapses to an incomplete, because the homework was never assigned.
Where do all those confident protocols actually come from, then?
Good question, and the honest answer is less impressive than the packaging suggests: convention and extrapolation, not outcome trials. The popular numbers accreted on forums over years, borrowed in part from research on growth hormone itself (a completely separate, FDA-regulated drug), and repeated until repetition started to look like proof. I’m not saying these numbers are reckless nonsense pulled from thin air. I’m saying they’re not what they’re dressed up as. The truest possible sentence about any “research-backed” CJC-1295 protocol you find online is: this is common practice, not something any human outcome study has validated, because that study doesn’t exist. If you remember one line from this whole review, make it that one. It’s more useful than any milligram figure I could hand you.
And that’s exactly why I’m not handing you one. Printing a tidy protocol here, dressed in a friendly explainer voice, would be the exact bait-and-switch this piece is trying to warn you about. What I can review honestly is what’s known (one study, DAC version, 30 to 60 mcg/kg, single dose, hormone readouts only) against what’s assumed (everything else), and point you toward getting an actual answer instead of a borrowed one.
The part the milligram math can’t fix
Let’s say, hypothetically, someone handed you a flawless dose. You’d still have a bigger problem: you have no idea what’s actually in the vial. Most CJC-1295 moves through the gray online peptide trade, arriving stamped “for research use only, not for human consumption.” Take that label at face value, because nobody verified that the contents match it, or that the potency is anywhere near what’s printed. Your careful calculation is being applied to an unverified powder, which makes the precision cosmetic.
This isn’t hypothetical hand-wringing either. Reporting in 2026 documented that gray-market injectable peptides can carry impurities including bacteria or heavy metals, with immune reactions ranging from mild to genuinely dangerous, and two women became critically ill after receiving FDA-flagged peptides at a 2025 event [P4]. A perfect dose of a wrong vial is still a wrong injection. That’s not a footnote, that’s the review’s main finding, if I’m being honest about what actually matters here.
There’s also the question a dose chart never asks: should you be doing this at all. The 2006 study itself flagged sustained IGF-1 elevation as something worth weighing against a person’s actual health situation before injecting a growth-hormone signal [P1]. A forum post doesn’t ask that question. Nor does it mention that CJC-1295’s largest trial, a Phase II study of 192 people, was halted in 2006 after a participant died following his eleventh weekly injection [P2]. In fairness, the reviewing physician attributed that death most likely to pre-existing coronary disease unrelated to the drug, and a competing trial was allowed to continue [P3]. That’s not a verdict of danger. It is, however, a pretty clear argument for why a real person weighing your case beats a copy-pasted number.
The honest grade
If I’m grading “figure out your own CJC-1295 dose from the internet” as a product, it earns a D. Not an F, because the underlying compound isn’t a scam and the one study that exists is legitimate science. But a D, because everything wrapped around that one study, the confident forum numbers, the unverified vials, the total silence on long-term use, is marketing dressed as research. You’re paying full attention price for partial information.
What actually earns a passing grade
The honest way to land on a number is to let a clinician decide one for you, applied to a product you can actually trust, after looking at your real situation. That’s not a dodge, it’s the only version of an answer that’s both safe and real, because a dose only means something once the vial is what it claims and someone qualified has judged whether the compound even suits you.
That’s the practical gap between a supervised route and a research vial. Under a licensed, clinician-directed model, someone reviews your history and medications and decides whether a growth-hormone secretagogue makes sense for you at all, a licensed pharmacy actually compounds and dispenses the product so you’re not guessing at contents, and there’s a person to call afterward. FormBlends operates as one of those licensed, clinician-directed setups, and that’s the only reason it’s named here: it represents the version of this path where “how much CJC-1295” reaches a credentialed person instead of a message board. Take that as me pointing at the road, not handing out a trophy. Supervision doesn’t make CJC-1295 a proven drug. The human evidence is still that one small study, either way. What supervision changes is that the dose is decided for you and the product it’s applied to has been verified, rather than both being left to you and a disclaimer nobody reads.
One more practically useful note while we’re being straight with each other: if you are working with a clinician, keeping a simple log of each dose and what you notice afterward turns a vague memory into something usable at your next visit. The FormBlends tracker app does exactly that, logging doses and symptoms over time. It writes no prescription and processes no sale, it’s just a record, which is more follow-up infrastructure than the buy-a-vial route offers, since that route ends the moment the cart closes. I mention it once, as the answer to “how do I keep track,” not as anything doing the dosing itself. It doesn’t.
The trade-off, stated plainly because you’ve earned a plain answer by now: compounded medications aren’t FDA-approved finished drugs, and the FDA doesn’t review them for safety, effectiveness, or quality the way it reviews mass-manufactured ones. Going the supervised route is slower than ordering a vial, and that fact doesn’t disappear. What you get for the wait is a real dosing decision made for your body, a verified product, and someone to follow up with, which is the whole case for calling this the honest answer rather than the convenient one.
One thing that overrides this entire review
If you compete in any tested sport, forget every number above. The correct dose is zero. CJC-1295 is named explicitly on the WADA 2026 Prohibited List as a banned growth-hormone-releasing factor under section S2.2.4, prohibited at all times, in and out of competition [P5]. A “research use only” sticker offers a tested athlete zero protection, and neither does a prescription. Check the current list yourself and treat this as the wall it is, not a suggestion.
The bottom line, review-style
Two versions, dosed on entirely different clocks, so know which one anybody’s talking about. One human study exists, DAC version, 30 to 60 micrograms per kilogram, single dose, and it’s validated for exactly one thing: moving a hormone number for a few days [P1]. Every polished protocol you’ll find online is convention wearing a lab coat, not clinical evidence, and it’s usually being poured into a vial nobody has verified. The path that actually earns trust is a clinician deciding your dose against a real product, with a log to make your follow-up mean something. And if you compete, the number is zero, no exceptions [P5].
Common questions
What’s the one CJC-1295 dose that’s actually backed by human data?
Exactly one exists: the DAC version, single injection, 30 to 60 micrograms per kilogram of body weight, from the 2006 trial in the Journal of Clinical Endocrinology and Metabolism [P1]. That dose raised growth hormone and IGF-1 for several days and nothing beyond that, so it’s validated for a brief hormone bump, not for any real-world outcome. Nobody has run the repeated-dosing, weeks-or-months version of this study.
Why are the two versions dosed so differently?
Because their shelf lives inside the body are wildly different. The DAC version binds to albumin and keeps signaling for days off one shot, so it’s used infrequently. The non-DAC version, sold as mod-GRF 1-29, clears in about half an hour and delivers a short pulse, so people time it around events like sleep and use it more often. Any number floating around without naming the version is not worth your attention.
Where do the “100 mcg twice a week” numbers actually come from?
Forum convention and extrapolation, not human trials. They built up over years, partly borrowed from research on growth hormone itself, a separate FDA-regulated drug entirely. When a page presents one as research-backed, the accurate translation is “widely repeated practice, unvalidated by any human outcome study,” because that study was never done. Keep that translation handy for anything you read on this topic.
Does buying from a gray-market peptide vendor make careful dosing pointless?
Mostly, yes. Precise math applied to an unverified vial is theater, not precision. Product usually arrives labeled “for research use only,” with nobody confirming the contents match the label or the strength. Reporting in 2026 documented gray-market peptides carrying impurities like bacteria or heavy metals, with two women becoming critically ill after receiving FDA-flagged peptides at a 2025 event [P4]. A well-calculated dose of an unknown substance is still an unknown injection.
If I compete in a tested sport, is there a safe amount?
No. Zero is the number. CJC-1295 sits explicitly on the WADA 2026 Prohibited List as a banned growth-hormone-releasing factor under section S2.2.4, prohibited at all times [P5]. A “research use only” label offers a tested athlete no cover, and neither does a prescription. Confirm the current list yourself and treat this as final.
So what’s the actually honest way to land on a dose?
Let a clinician decide one for you, applied to a verified product, after reviewing your actual situation. A licensed setup means your history and medications get reviewed, a licensed pharmacy compounds and dispenses what you take so you’re not guessing at contents, and there’s follow-up available. A simple log of doses and effects makes that follow-up genuinely worth something. This route is slower than buying a vial and doesn’t turn CJC-1295 into a proven drug, but the dose you land on is real and the product behind it has been checked.
What does CJC-1295 actually do in the body?
CJC-1295 binds to receptors in the pituitary gland and prompts it to release more growth hormone. Think of it as turning up the volume on a signal your body already sends, rather than injecting growth hormone directly. The DAC version extends that signal for days; the non-DAC version fades within hours. Whether that translates to meaningful muscle gain or fat loss in healthy adults is still an open question, not a settled one.
What side effects show up most often with CJC-1295?
The most commonly reported ones are water retention, joint aches, tingling or numbness in the hands, and temporary flushing or redness at the injection site. Elevated growth hormone also raises IGF-1, and sustained high IGF-1 carries theoretical long-term concerns including insulin resistance. The honest caveat is that most side-effect reports come from forums, not controlled trials, so frequency data is genuinely unreliable.
Is CJC-1295 legal to buy and use?
The legal picture depends heavily on where you are and where you source it. In the United States, CJC-1295 is not FDA-approved as a drug, so selling it as a supplement or research chemical occupies a legal gray zone. It can, however, be compounded by a licensed pharmacy for a specific patient under a physician’s order, which is the accountable route some people pursue through places like FormBlends. Buying raw peptide powder online sits in a very different legal category.
How much does purity actually vary between CJC-1295 sources, and why does it matter for dosing?
Purity varies a lot, and that variation breaks any dose calculation you try to make. Third-party lab testing of research-chemical peptides has repeatedly found products that are underdosed, mislabeled, or contaminated with residual solvents. If a vial labeled 2 mg is actually 1.2 mg of mixed purity, your careful math means nothing. This is why sourcing and dose accuracy are inseparable conversations, not two separate ones.
References
- Single-dose CJC-1295 with DAC at 30 to 60 mcg/kg raised growth hormone 2- to 10-fold for 6+ days and IGF-1 for 9 to 11 days in healthy adults; estimated half-life 5.8 to 8.1 days; relatively well tolerated over a short follow-up; the trial measured hormone levels, not clinical outcomes. Teichman SL, et al. Journal of Clinical Endocrinology and Metabolism, 2006. https://pubmed.ncbi.nlm.nih.gov/16352683/
- ConjuChem’s Phase II CJC-1295 (DAC:GRF) study in 192 people with HIV-related visceral fat was halted in July 2006 after a participant died following his eleventh weekly injection. aidsmap, July 2006.
- The attending physician concluded the death was most likely caused by pre-existing, asymptomatic coronary artery disease with plaque rupture and was unrelated to treatment with CJC-1295; a competing GRF drug’s trial was allowed to continue; the compound was never approved. Encyclopedic summary of CJC-1295 development history.
- Injectable peptides in the gray market can carry impurities including bacteria or heavy metals and provoke immune reactions up to anaphylaxis; two women became critically ill after receiving FDA-flagged peptides at a 2025 event. ProPublica, April 2026.
- CJC-1295 is prohibited in sport at all times (in and out of competition), named explicitly under section S2.2.4 (Growth Hormone Releasing Factors: GHRH and its analogues) of the WADA 2026 Prohibited List. World Anti-Doping Agency, 2026. https://www.wada-ama.org/en/prohibited-list
